CAMP4 Therapeutics Statistics
NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.84-0.12 (-3.03%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CAMP4 Therapeutics by the numbers
CAMP4 Therapeutics has a market capitalization of $241.0 million based on 62.75M shares outstanding. With trailing EPS of $-2.32, CAMP4 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.7% below its 50-day average and 13.7% below its 200-day average.
Average daily trading volume is 279.95K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CAMP valuation vs. peer median
| Metric | CAMP | Peer median | Difference |
|---|---|---|---|
| Market cap | $240.97M | $240.08M | +0% |
| Avg. volume | 279.95K | 497.62K | -44% |
Peer median across 8 companies: PYXS, VOGX, AKBA, VCRE, QTTB, LFCR, SLGL, SIGA.
Valuation
- Market cap
- $240.97M
- EPS (TTM)
- $-2.32
- Shares outstanding
- 62.75M
Price and trading
- Previous close
- 3.96
- Open
- 3.85
- Day range
- 3.84 – 4.09
- 52-week range
- 2.86 – 7.75
- 52-week change
- +16.72%
- Beta
- —
- Volume
- 148.50K
- Average volume
- 279.95K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 240.97M
- Forward Pe
- -4.75
- Eps
- -2.32
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.75
- Week52 Low
- 2.86
- Avg Volume
- 279.95K
- Shares Outstanding
- 62.75M
- Ma50
- 4.16
- Ma200
- 4.45
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -50.45%
- Pct From52w Low
- 34.27%